Overview

Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214

Status:
Withdrawn
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This is a single dose, crossover study to assess the abuse potential of TC-5214 compared to placebo, ketamine, and phentermine in healthy recreational polydrug users.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ketamine
Phentermine